ENDO Financials Monday, July 14, 2014 11:42:23 PM

ENDO Financials Monday, July 14, 2014 11:42:23 PM
Endocan Corporation
Period Ending Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue - - -
Cost of Revenue - - -
Gross Profit - - -
Operating Expenses
Research and Development - - -
Sales, General and Admin. 488 45 127
Non-Recurring Items 255 66 -
Other - - -
Operating Income (743) (111) (127)
Income From Continuing Operations
Add'l Income/Expense Items (600) (1,647) (76)
Earnings Before Interest and Tax (1,343) (1,758) (204)
Interest Expense 1,968 223 5,100
Earnings Before Tax (3,311) (1,981) (5,304)
Income Tax - - -
Minority Interest - - -
Equity Earnings Unconsolidated Subsidiary - - -
Net Income Cont. Operations (3,311) (1,981) (5,304)
Non Recurring Events
Discontinued Operations - - -
Extraordinary Items - - -
Effect of Accounting Changes - - -
Other Items - - -
Net Income (3,311) (1,981) (5,304)
Preferred Stock and Other Adjustments - - -
Net Income Applicable to Common Shareholders (3,311) (1,981) (5,304)